Search details
1.
Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes.
Cell
; 184(8): 2239-2254.e39, 2021 04 15.
Article
in English
| MEDLINE | ID: mdl-33831375
2.
Drosha controls dendritic cell development by cleaving messenger RNAs encoding inhibitors of myelopoiesis.
Nat Immunol
; 16(11): 1134-41, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26437240
3.
The evolutionary history of 2,658 cancers.
Nature
; 578(7793): 122-128, 2020 02.
Article
in English
| MEDLINE | ID: mdl-32025013
4.
Author Correction: The evolutionary history of 2,658 cancers.
Nature
; 614(7948): E42, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36697833
5.
Prostate cancer cell-intrinsic interferon signaling regulates dormancy and metastatic outgrowth in bone.
EMBO Rep
; 21(6): e50162, 2020 06 04.
Article
in English
| MEDLINE | ID: mdl-32314873
6.
A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance.
Br J Cancer
; 114(4): 454-62, 2016 Feb 16.
Article
in English
| MEDLINE | ID: mdl-26812572
7.
A microRNA expression atlas of mouse dendritic cell development.
Immunol Cell Biol
; 93(5): 480-5, 2015.
Article
in English
| MEDLINE | ID: mdl-25533289
8.
Socrates: identification of genomic rearrangements in tumour genomes by re-aligning soft clipped reads.
Bioinformatics
; 30(8): 1064-1072, 2014 04 15.
Article
in English
| MEDLINE | ID: mdl-24389656
9.
Slinker: Visualising novel splicing events in RNA-Seq data.
F1000Res
; 10: 1255, 2021.
Article
in English
| MEDLINE | ID: mdl-35035899
10.
MINTIE: identifying novel structural and splice variants in transcriptomes using RNA-seq data.
Genome Biol
; 22(1): 296, 2021 10 22.
Article
in English
| MEDLINE | ID: mdl-34686194
11.
Loss of SNAI2 in Prostate Cancer Correlates With Clinical Response to Androgen Deprivation Therapy.
JCO Precis Oncol
; 52021 06.
Article
in English
| MEDLINE | ID: mdl-34322653
12.
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer.
Prostate Cancer Prostatic Dis
; 24(4): 1167-1180, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34108644
13.
Inferring structural variant cancer cell fraction.
Nat Commun
; 11(1): 730, 2020 02 05.
Article
in English
| MEDLINE | ID: mdl-32024845
14.
Using equivalence class counts for fast and accurate testing of differential transcript usage.
F1000Res
; 8: 265, 2019.
Article
in English
| MEDLINE | ID: mdl-31143443
15.
Author Correction: Inferring structural variant cancer cell fraction.
Nat Commun
; 13(1): 7568, 2022 Dec 08.
Article
in English
| MEDLINE | ID: mdl-36481724
16.
Comparing nodal versus bony metastatic spread using tumour phylogenies.
Sci Rep
; 6: 33918, 2016 Sep 22.
Article
in English
| MEDLINE | ID: mdl-27653089
17.
Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression.
Oncotarget
; 7(21): 31384-92, 2016 May 24.
Article
in English
| MEDLINE | ID: mdl-27120785
18.
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.
Nat Commun
; 6: 6605, 2015 Apr 01.
Article
in English
| MEDLINE | ID: mdl-25827447
Results
1 -
18
de 18
1
Next >
>>